Etienne Macedo1, Ravindra L Mehta. 1. Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, San Diego, California, USA.
Abstract
PURPOSE OF REVIEW: Prerenal failure is used to designate a reversible form of acute renal dysfunction. However, the terminology encompasses several different conditions that vary considerably. The lack of a widely accepted definition for prerenal failure makes it impossible to determine the epidemiology, natural history, and association with adverse outcomes. RECENT FINDINGS: New diagnostic and staging criteria for acute kidney injury proposed by the Acute Kidney Injury (AKI) Network recognize that small increases in serum creatinine are associated with increased mortality. However, these criteria have not determined specific diagnostic criteria to classify prerenal conditions. As a consequence of the lack of standardized definitions and the difficulty in assessing reversibility of AKI, the concept of prerenal failure has been recently challenged. The difference in the pathophysiology and manifestations of prerenal failure suggests that our current approach needs to be reevaluated. SUMMARY: Prerenal failure state needs to be classified depending on the underlying capacity for compensation, the nature and the timing of the insult and the adaptation to chronic comorbidities. Identification of high-risk states and high-risk processes associated with the use of new biomarkers for AKI will provide new tools to distinguish between the prerenal failure and the established AKI. This review provides an appraisal of the current status and recommendations for future research in this field.
PURPOSE OF REVIEW: Prerenal failure is used to designate a reversible form of acute renal dysfunction. However, the terminology encompasses several different conditions that vary considerably. The lack of a widely accepted definition for prerenal failure makes it impossible to determine the epidemiology, natural history, and association with adverse outcomes. RECENT FINDINGS: New diagnostic and staging criteria for acute kidney injury proposed by the Acute Kidney Injury (AKI) Network recognize that small increases in serum creatinine are associated with increased mortality. However, these criteria have not determined specific diagnostic criteria to classify prerenal conditions. As a consequence of the lack of standardized definitions and the difficulty in assessing reversibility of AKI, the concept of prerenal failure has been recently challenged. The difference in the pathophysiology and manifestations of prerenal failure suggests that our current approach needs to be reevaluated. SUMMARY:Prerenal failure state needs to be classified depending on the underlying capacity for compensation, the nature and the timing of the insult and the adaptation to chronic comorbidities. Identification of high-risk states and high-risk processes associated with the use of new biomarkers for AKI will provide new tools to distinguish between the prerenal failure and the established AKI. This review provides an appraisal of the current status and recommendations for future research in this field.
Authors: T R Miller; R J Anderson; S L Linas; W L Henrich; A S Berns; P A Gabow; R W Schrier Journal: Ann Intern Med Date: 1978-07 Impact factor: 25.391
Authors: Thomas L Nickolas; Kai M Schmidt-Ott; Pietro Canetta; Catherine Forster; Eugenia Singer; Meghan Sise; Antje Elger; Omar Maarouf; David Antonio Sola-Del Valle; Matthew O'Rourke; Evan Sherman; Peter Lee; Abdallah Geara; Philip Imus; Achuta Guddati; Allison Polland; Wasiq Rahman; Saban Elitok; Nasir Malik; James Giglio; Suzanne El-Sayegh; Prasad Devarajan; Sudarshan Hebbar; Subodh J Saggi; Barry Hahn; Ralph Kettritz; Friedrich C Luft; Jonathan Barasch Journal: J Am Coll Cardiol Date: 2012-01-17 Impact factor: 24.094
Authors: Jeffrey D Pressly; Suni M Mustafa; Ammaar H Adibi; Sahar Alghamdi; Pankaj Pandey; Kuldeep K Roy; Robert J Doerksen; Bob M Moore; Frank Park Journal: J Pharmacol Exp Ther Date: 2017-11-29 Impact factor: 4.030
Authors: Eugenia Singer; Antje Elger; Saban Elitok; Ralph Kettritz; Thomas L Nickolas; Jonathan Barasch; Friedrich C Luft; Kai M Schmidt-Ott Journal: Kidney Int Date: 2011-03-16 Impact factor: 10.612
Authors: Katherine Xu; Paul Rosenstiel; Neal Paragas; Christian Hinze; Xiaobo Gao; Tian Huai Shen; Max Werth; Catherine Forster; Rong Deng; Efrat Bruck; Roger W Boles; Alexandra Tornato; Tejashree Gopal; Madison Jones; Justin Konig; Jacob Stauber; Vivette D'Agati; Hediye Erdjument-Bromage; Subodh Saggi; Gebhard Wagener; Kai M Schmidt-Ott; Nicholas Tatonetti; Paul Tempst; Juan A Oliver; Paolo Guarnieri; Jonathan Barasch Journal: J Am Soc Nephrol Date: 2016-12-27 Impact factor: 10.121
Authors: John W Simmons; Kevin K Chung; Evan M Renz; Christopher E White; Casey L Cotant; Molly A Tilley; Mark O Hardin; John A Jones; Lorne H Blackbourne; Steven E Wolf Journal: BMC Anesthesiol Date: 2010-06-24 Impact factor: 2.217
Authors: Maryam Nejat; John W Pickering; Prasad Devarajan; Joseph V Bonventre; Charles L Edelstein; Robert J Walker; Zoltán H Endre Journal: Kidney Int Date: 2012-03-14 Impact factor: 10.612